Caine S.B., Koob G.F.
Department of Neuropharmacology, The Scripps Research Institute, CVN-7 La Jolla, CA 92037, USA.
Behav Pharmacol. 1995 Jun;6(4):333-347.
This study tested the hypothesis that administration of the dopamine agonist 7-hydroxy-N,N-di-n-propyl-2-aminotetralin (7-OH-DPAT) shifts the cocaine self-administration dose-effect function to the left, rather than producing nonspecific effects or exclusively enhancing the rate-decreasing effects of high doses of cocaine. Under fixed-ratio or progressive-ratio schedules, rats were allowed to intravenously self-administer cocaine, 7-OH-DPAT, or a combination of cocaine and 7-OH-DPAT. In additional tests under fixed-ratio schedules, cocaine self-administration followed subcutaneous pretreatment with 7-OH-DPAT. Cocaine dose-effect functions were obtained by varying the unit dose of cocaine either between test sessions or within a single session. Intravenous 7-OH-DPAT (1-4µg) decreased self-administration of the training dose of cocaine (0.25mg) under a fixed-ratio schedule, but failed to shift the entire cocaine self-administration dose-effect function to the left under fixed-ratio or progressive-ratio schedules. 7-OH-DPAT alone maintained i.v. self-administration under these schedules, but produced a shallow self-administration dose-effect function, relative to cocaine, under the progressive-ratio schedule. In contrast to intravenous 7-OH-DPAT, s.c. pretreatment with 7-OH-DPAT (0.1-0.4mg/kg) not only decreased self-administration of the training dose of cocaine but also lowered the minimum effective dose of cocaine under fixed-ratio schedules, producing a shift to the left of the cocaine self-administration dose-effect function; these effects were independent of whether the dose of cocaine was varied between sessions or within a single session. Likewise under a multiple schedule, in which responding was maintained by cocaine and food in alternate components, s.c. pretreatment with 7-OH-DPAT increased self-administration of the dose of cocaine on the ascending limb of the dose-effect function and decreased self-administration of doses of cocaine on the descending limb, while uniformly decreasing responding for food. These observations suggest that pretreatment with 7-OH-DPAT enhances the reinforcing properties of cocaine rather than producing nonspecific effects or enhancing exclusively the rate-decreasing effects of high doses of self-administered cocaine.
给予多巴胺激动剂7-羟基-N,N-二正丙基-2-氨基四氢萘(7-OH-DPAT)会使可卡因自我给药剂量效应函数向左移动,而不是产生非特异性效应或仅仅增强高剂量可卡因的降低反应率效应。在固定比率或累进比率给药方案下,让大鼠静脉内自我给药可卡因、7-OH-DPAT或可卡因与7-OH-DPAT的组合。在固定比率给药方案下的额外试验中,在皮下注射7-OH-DPAT预处理后进行可卡因自我给药。通过在不同试验时段之间或在单个试验时段内改变可卡因的单位剂量来获得可卡因剂量效应函数。静脉注射7-OH-DPAT(1-4μg)在固定比率给药方案下减少了训练剂量可卡因(0.25mg)的自我给药,但在固定比率或累进比率给药方案下未能使整个可卡因自我给药剂量效应函数向左移动。单独使用7-OH-DPAT在这些给药方案下维持静脉内自我给药,但在累进比率给药方案下,相对于可卡因,产生了较浅的自我给药剂量效应函数。与静脉注射7-OH-DPAT相反,皮下注射7-OH-DPAT(0.1-0.4mg/kg)预处理不仅减少了训练剂量可卡因的自我给药,还降低了固定比率给药方案下可卡因的最小有效剂量,使可卡因自我给药剂量效应函数向左移动;这些效应与可卡因剂量是在不同试验时段之间还是在单个试验时段内变化无关。同样,在多重给药方案下,即在交替成分中通过可卡因和食物维持反应,皮下注射7-OH-DPAT预处理增加了剂量效应函数上升支上可卡因剂量的自我给药,并减少了剂量效应函数下降支上可卡因剂量的自我给药,同时一致地减少了对食物的反应。这些观察结果表明,7-OH-DPAT预处理增强了可卡因的强化特性, 而不是产生非特异性效应或仅仅增强自我给药高剂量可卡因的降低反应率效应。